Oculofacial-skeletal myorhythmia in central nervous system Whipple's disease: additional case and review of the literature

Movement Disorders : Official Journal of the Movement Disorder Society
D A SimpsonA M Pawlak

Abstract

A case of oculofacial-skeletal myorhythmia associated with cerebral Whipple's disease is presented. This peculiar abnormal movement disorder consists of a convergent-divergent pendular nystagmus associated with a synchronous, rhythmic movement of the mouth, jaw, and extremities. The movements in previous cases have responded inconsistently to a variety of broad-spectrum antibiotic drugs, and antiepileptic, muscle relaxant, antispastic, and psychotropic drugs. The current patient's mental status improved after starting intravenous ceftriaxone but improvement of the abnormal movements occurred only after the addition of oral valproate. Current treatment consists of intravenous trimethoprim-sulfamethoxazole for 2 weeks followed by oral trimethoprim-sulfamethoxazole twice daily for 1 year. Presented here is an alternative treatment of intravenous ceftriazone followed by oral trimethoprim-sulfamethoxazole in combination with valproate for abnormal movements not responsive to antibiotic drugs alone.

References

Dec 19, 1975·Acta Neuropathologica·T Kitamura
Sep 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·F C RomanulR K Rosales
Dec 1, 1979·Acta Neuropathologica·J M Powers, S E Rawe
Jan 1, 1992·Movement Disorders : Official Journal of the Movement Disorder Society·F TisonE Gaujard
Mar 15, 1990·Annals of Internal Medicine·C H Adler, S L Galetta
Sep 1, 1990·Journal of Computer Assisted Tomography·T DavionJ P Capron
Oct 1, 1990·Journal of Neurosurgery·A P BrownD G Vollmer
Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·P AmarencoR Marteau
Nov 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·S J WroeS Shorvon
Dec 1, 1991·Journal of Neurology, Neurosurgery, and Psychiatry·P K Yip
Jan 1, 1986·Digestive Diseases·U A MarbetK E Gyr
Jan 1, 1987·Annals of Neurology·M AdamsE A Smuckler
Sep 1, 1987·Annals of Neurology·J C GrottaS Snatic
Jan 1, 1988·Movement Disorders : Official Journal of the Movement Disorder Society·C Hausser-HauwR Marteau
Oct 16, 1986·The New England Journal of Medicine·M R Sears
Apr 1, 1974·Experimental Neurology·J L Crockett, V R Edgerton
Oct 1, 1980·American Journal of Clinical Pathology·L Johnson, I Diamond
Nov 1, 1980·Annals of Internal Medicine·M FeldmanE B Morrison
Dec 1, 1981·Journal of Neurology, Neurosurgery, and Psychiatry·S PollockB Kendall
Jun 1, 1982·Neurology·J J HalperinG M Kleinman
Mar 1, 1984·Brain : a Journal of Neurology·E F MasucciN Saini
Apr 1, 1963·Journal of the American Geriatrics Society·J L BENTONW C MUMLER
Mar 1, 1965·Brain : a Journal of Neurology·W T SMITHJ A WAKES-MILLER
Jan 1, 1960·Journal of Neuropathology and Experimental Neurology·J C SIERACKIJ BEBIN

❮ Previous
Next ❯

Citations

Sep 24, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·T KatoG J Lavigne
Oct 1, 1996·Annals of Neurology·E D LouisJ Odel
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·A H Rajput, J D McHattie
Jul 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·E PeruccaF Savoldi
Jul 11, 2006·Current Infectious Disease Reports·Mara M Lugassy, Elan D Louis
Nov 1, 1996·Clinical Neurology and Neurosurgery·W I VerhagenM M Schuurmans
Dec 6, 2001·Ophthalmology·R Y ChanC S Foster
Feb 28, 2008·Current Opinion in Gastroenterology·Thomas Marth, Thomas Schneider
Nov 21, 2000·Postgraduate Medical Journal·R N Ratnaike
Oct 31, 2002·Journal of Neurosurgery·Ziya AkarCengiz Kuday
May 10, 2013·Acta neurologica Belgica·Evelien VancaesterPatrick Santens
Feb 6, 2009·Acta neurochirurgica·James L Frazier, Alfredo Quinones-Hinojosa
Dec 2, 2006·Journal of the Neurological Sciences·Eng-King TanYew-Long Lo
Mar 23, 2017·Journal of the Neurological Sciences·Sarah Kang, Aasef G Shaikh
Oct 10, 2007·Clinical Neurology and Neurosurgery·Liyong WuJianping Jia
Dec 10, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·José Fidel Baizabal-CarvalloJoseph Jankovic
Oct 20, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Julien F BallyAnthony E Lang
Jun 9, 2005·Expert Review of Neurotherapeutics·Scott B Patten
Mar 18, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Robert J UreAlfonso Fasano
Jul 28, 2014·Movement Disorders Clinical Practice·Toshiaki TakeuchiRyuji Kaji
Apr 1, 1997·Annals of Neurology·P J SchniderE Auff

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
C Hausser-HauwR Marteau
Movement Disorders : Official Journal of the Movement Disorder Society
A H Rajput, J D McHattie
© 2021 Meta ULC. All rights reserved